Base Year
Historical Year
Forecast Year
The global breast cancer therapeutics market size was USD 33.46 billion in 2023, driven by the rising incidence of breast cancer across the globe. The market size is anticipated to grow at a CAGR of 10.8% during the forecast period of 2024-2032 to achieve a value of USD 84.22 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Breast cancer is common in women across the globe and a major reason of cancer related deaths in women. It has been suggested that in USA, over 250,000 fresh cases of invasive breast cancer would be identified in women in 2023, while over forty thousand women are estimated to die of the disease. Breast cancer generally develops in middle-aged and older women. It is noteworthy that men are also prone to breast cancer, though to a very lesser degree. Continual research has led to significant transformation in breast cancer care; procedures such as mastectomy and chemotherapy, along with developments in screening and diagnosis (mammography) and improved disease awareness have considerably enhanced the chances of survival of people suffering from breast cancer.
Symptoms may include lump or thickening feeling dissimilar to surrounding tissue, changes crusting, peeling, or flaking of the pigmented site around the areola or breast skin, pitting or redness of skin over the breast, and others.
Developments in molecular biology, systems biology and genome sciences have offered a deeper understanding of breast cancer at various levels, including genomic, molecular and cellular. Biologically, breast cancer is one of the several types of tumour with multiple factors driving its progression and development.
Companies seek to enhance outcomes of breast cancer patients through scientific innovations and possible path-breaking medicines. Treatments of breast cancer include chemotherapy, surgery, and therapies including biological, hormonal, and radiation. Drugs that have been approved to treat breast cancer include Abemaciclib, Capecitabine, Doxorubicin Hydrochloride, Epirubicin Hydrochloride, Fareston (Toremifene), Gemzar (Gemcitabine Hydrochloride), Halaven (Eribulin Mesylate), and others. Combinations used to treat breast cancer include AC-T, AC, CMF, CAF, FEC, and TAC.
In 2023, AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) was afforded Breakthrough Therapy Designation in USA for patients with HER2-low metastatic breast cancer. Such developments are likely to stimulate the global breast cancer therapeutics market.
In 2021, Verzenio® (abemaciclib) was approved by the FDA as the initial and lone CDK4/6 inhibitor for individuals with HR+ HER2- high risk early breast cancer.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By therapy, the market is segmented into:
By cancer type, the market is classified into:
By distribution channel, the market is divided into:
By region, the market is segmented into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report extensively analyses major players in the global breast cancer therapeutics market, evaluating their capacity and monitoring latest developments like plant turnarounds, capacity expansions, and mergers and acquisitions:
The EMR report offers deep industry insights through a SWOT analysis and Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Therapy |
|
| Breakup by Cancer Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The breast cancer therapeutics market was valued at USD 33.46 billion in 2023.
The market is expected to grow at a CAGR of 10.8% from 2024 to 2032 to reach a value of USD 84.22 billion by 2032.
The major market drivers are technological advancements and the growing incidence of breast cancer.
The key market trends include increasing investments in research and development, coupled with the launch of several diagnostic and screening programs.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The various therapies of breast cancer therapeutics in the market include targeted therapy, hormonal therapy, and chemotherapy.
The various cancer types of breast cancer therapeutics in the market include hormone receptor and HER2+.
The various distribution channels of breast cancer therapeutics in the market include retail pharmacies, hospital pharmacies, and online pharmacies, among others.
The major players in the market are Eli Lilly and Company, Genentech, Inc., AstraZeneca, Novartis AG, and Sanofi, among others.
Breast cancer is a known as a disease in which cells in the breast grow out of control.
Women who have inherited changes also known as mutations to specific genes, like BRCA1 and BRCA2, are at higher risk of breast and ovarian cancer.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share